Role of cMET in the development and progression of colorectal cancer.

Int J Mol Sci · 2013 · PMC3794769 · PMID 24005867

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Median PFS showed a trend for improvement in the combination treatment at 5.2 months compared with 3.7 months in the panitumumab-placebo arm [ 100 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.